Results 1 to 10 of about 29,142 (301)

Unveiling Hybrid Ameloblastoma: Uncommon Variant With Unique Diagnostic Challenges [PDF]

Clinical Case Reports
Ameloblastoma is a benign tumor originating from odontogenic tissue and has various histological subtypes. It accounts for approximately 18% of all odontogenic tumors.
Dilasha Dhungel, Varun Rastogi, Sandhya Chaurasia, Priyambada Karna   +3 more
doaj   +3 more sources

Molecular biological findings of ameloblastoma

Japanese Dental Science Review, 2021
Ameloblastoma is benign odontogenic tumours that mainly occur in the jawbone. This tumour induces aggressive invasion into the surrounding bone and has a high recurrence rate after surgery.
Takao Fuchigami, Yusuke Ono, Shosei Kishida, Norifumi Nakamura   +3 more
doaj   +2 more sources

Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma

Cancer Medicine, 2020
Ameloblastoma is a rare odontogenic benign tumor accounting for less than 1% of head and neck tumors. Advanced next generation sequencing (NGS) analyses identified high frequency of BRAF V600E and SMO L412F mutations in ameloblastoma.
Sayuri Kondo, Akinobu Ota, Takayuki Ono, Sivasundaram Karnan, Md Wahiduzzaman, Toshinori Hyodo, Md Lutfur Rahman, Kunihiro Ito, Akifumi Furuhashi, Tomio Hayashi, Hiroyuki Konishi, Shinobu Tsuzuki, Yoshitaka Hosokawa, Yoshiaki Kazaoka   +13 more
doaj   +2 more sources

Single-cell transcriptomics reveals cell atlas and identifies cycling tumor cells responsible for recurrence in ameloblastoma

International Journal of Oral Science
Ameloblastoma is a benign tumor characterized by locally invasive phenotypes, leading to facial bone destruction and a high recurrence rate. However, the mechanisms governing tumor initiation and recurrence are poorly understood.
Gan Xiong, Nan Xie, Min Nie, Rongsong Ling, Bokai Yun, Jiaxiang Xie, Linlin Ren, Yaqi Huang, Wenjin Wang, Chen Yi, Ming Zhang, Xiuyun Xu, Caihua Zhang, Bin Zou, Leitao Zhang, Xiqiang Liu, Hongzhang Huang, Demeng Chen, Wei Cao, Cheng Wang   +19 more
doaj   +2 more sources

Glandular odontogenic cyst associated with ameloblastoma : case report and review of the literature [PDF]

, 2017
Glandular odontogenic cyst (GOC) associated with ameloblastoma is an exceedingly rare histologic presentation with no known clinical significance or treatment applications. Four cases have been reported, three in the mandible and one in the maxilla.
Bobek, Samuel, Cousin, Timothée, Oda, Dolphine   +2 more
core   +2 more sources

Bioengineering the ameloblastoma tumour to study its effect on bone nodule formation

Scientific Reports, 2021
Ameloblastoma is a benign, epithelial cancer of the jawbone, which causes bone resorption and disfigurement to patients affected. The interaction of ameloblastoma with its tumour stroma drives invasion and progression.
Deniz Bakkalci, Amrita Jay, Azadeh Rezaei, Christopher A. Howard, Håvard Jostein Haugen, Judith Pape, Shosei Kishida, Michiko Kishida, Gavin Jell, Timothy R. Arnett, Stefano Fedele, Umber Cheema   +11 more
doaj   +2 more sources

Adenoid ameloblastoma harbors beta-catenin mutations [PDF]

Modern Pathology, 2022
Victor Coutinho Bastos, Bruna Pizziolo Coura, Letícia Martins Guimarães, Bianca Gomes Fernandes, Alexander Chak-Lam Chan, Pablo Agustín Vargas, Luciana Bastos‐Rodrigues, Luiz Marco, John W. Hellstein, Selvam Thavaraj, John M. Wright, Edward Odell, Ricardo Santiago Gomez, Carolina Cavaliéri Gomes   +13 more
openalex   +2 more sources

Ameloblastoma: An Updated Narrative Review of an Enigmatic Tumor

Cureus, 2022
Ameloblastoma is one of the most common benign odontogenic tumors of the jaw that constitutes about 10% of all tumors that arise in the mandible and maxilla.
S. Ghai
semanticscholar   +1 more source

Clinicopathologic Profile, Management and Outcome of Sinonasal Ameloblastoma—A Systematic Review

Journal of Clinical Medicine, 2023
Sinonasal ameloblastoma (SNA) is considered to be a subtype of ameloblastoma. It differs from gnathic ameloblastoma in terms of clinicopathologic features, management and prognosis. Thus, the objective of the present review was to study the complications,
Vini Mehta, G. Sarode, Vishnu Teja Obulareddy, Tanvi Sharma, Shruti Kokane, M. Cicciù, G. Minervini   +6 more
semanticscholar   +1 more source

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

Medical Oncology, 2023
Background Ameloblastoma in 66% of the cases harbor a somatic mutation of the “mitogen-activated protein kinase” signaling pathway (BRAF V600E). In V600E mutations, BRAF is in the permanent “on” state and relays the growth-promoting signals independently
M. Ebeling, Mario Scheurer, A. Sakkas, S. Pietzka, A. Schramm, F. Wilde   +5 more
semanticscholar   +1 more source